Mode
Text Size
Log in / Sign up
Phase 4 N=820 Randomized Single-blind Treatment

Smokers' Health Project: Self-Determination and Maintaining Tobacco Abstinence

Tobacco Use Disorder

Enrolled (actual)
820
Serious AEs
1.6%
Results posted
Feb 2013
Primary outcome: Primary: 12 Month Prolonged Abstinence From Tobacco Measured at 12 Months From Completion of Intervention. — 169; 321; 318 participants

Study Design & Population

Study type
Interventional
Phase
Phase 4
Interventions
Self-determination Intervention for Tobacco Dependence (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
University of Rochester
Primary completion
Aug 2008

Outcome Measures

OutcomeResultp-value
PRIMARY
12 Month Prolonged Abstinence From Tobacco Measured at 12 Months From Completion of Intervention.
169; 321; 318
SECONDARY
7 Day Point Prevelence (7DPP)
169; 321; 318

Summary

These two studies will examine the role of autonomous motivation in maintained adherence. The first study will determine whether smokers are still abstinent from tobacco 32 months after starting in a previous project (Smoker's Health Study). The purpose of the second study is to determine which of three treatments for tobacco dependence provides the greatest amount of protection from relapsing to smoking after quitting. Specifically, the investigators will determine if extending the length of treatment time focusing on relapse prevention and arranging for support from important others prevents relapse compared to community care. Also, the investigators will determine if providing extended treatment time and support from important others plus providing medications to those that don't want to quit prevents long term relapse compared to just extending the length of treatment time and support from others. Additionally, a sub set of the population will be randomized to using hand held palm devices to recover real-time data assessment during the last 10 months of the project.

Eligibility Criteria

Inclusion Criteria

  • Smoking 5 or more cigarettes per day.
  • 18 years of age or older.
  • Speak and read English.
  • Eligible regardless of desire to quit smoking

Exclusion Criteria

  • Pregnancy
  • History of psychotic illness other than depression
  • Life expectancy of less than 24 months
  • Dementia, or incompetence for medical decision making
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00178685). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search